1. Home
  2. SHMD vs KYTX Comparison

SHMD vs KYTX Comparison

Compare SHMD & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHMD
  • KYTX
  • Stock Information
  • Founded
  • SHMD 1864
  • KYTX 2018
  • Country
  • SHMD Germany
  • KYTX United States
  • Employees
  • SHMD N/A
  • KYTX N/A
  • Industry
  • SHMD
  • KYTX
  • Sector
  • SHMD
  • KYTX
  • Exchange
  • SHMD Nasdaq
  • KYTX NYSE
  • Market Cap
  • SHMD 144.3M
  • KYTX 166.4M
  • IPO Year
  • SHMD N/A
  • KYTX 2024
  • Fundamental
  • Price
  • SHMD $2.30
  • KYTX $3.41
  • Analyst Decision
  • SHMD
  • KYTX Buy
  • Analyst Count
  • SHMD 0
  • KYTX 5
  • Target Price
  • SHMD N/A
  • KYTX $23.20
  • AVG Volume (30 Days)
  • SHMD 46.3K
  • KYTX 308.0K
  • Earning Date
  • SHMD 02-25-2025
  • KYTX 02-12-2025
  • Dividend Yield
  • SHMD N/A
  • KYTX N/A
  • EPS Growth
  • SHMD 1309.32
  • KYTX N/A
  • EPS
  • SHMD 1.07
  • KYTX N/A
  • Revenue
  • SHMD $99,752,404.00
  • KYTX N/A
  • Revenue This Year
  • SHMD N/A
  • KYTX N/A
  • Revenue Next Year
  • SHMD N/A
  • KYTX N/A
  • P/E Ratio
  • SHMD $2.30
  • KYTX N/A
  • Revenue Growth
  • SHMD N/A
  • KYTX N/A
  • 52 Week Low
  • SHMD $1.98
  • KYTX $3.22
  • 52 Week High
  • SHMD $6.13
  • KYTX $30.60
  • Technical
  • Relative Strength Index (RSI)
  • SHMD N/A
  • KYTX 37.34
  • Support Level
  • SHMD N/A
  • KYTX $3.22
  • Resistance Level
  • SHMD N/A
  • KYTX $3.53
  • Average True Range (ATR)
  • SHMD 0.00
  • KYTX 0.25
  • MACD
  • SHMD 0.00
  • KYTX 0.00
  • Stochastic Oscillator
  • SHMD 0.00
  • KYTX 13.46

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

Share on Social Networks: